AbbVie Review - Search Videos

Infinity Pharma teams up with AbbVie for cancer drug

Infinity Pharma teams up with AbbVie for cancer drug

Infinity Pharma will receive $275 million upfront from AbbVie, as part of a new venture to develop blood cancer treatments. Infinity CEO Adelene Q. Perkins, explains the significance of the deal, with CNBC's Meg Tirrell.

CNBCJul 12, 2017

AbbVie Products

Understanding Eczema in 60 Seconds

Understanding Eczema in 60 Seconds

1.7M viewsJan 25, 2023

The World’s Best-Selling Drug Just Lost a Key Patent Battle

The World’s Best-Selling Drug Just Lost a Key Patent Battle

FortuneSy Mukherjee

AbbVie to acquire ImmunoGen in $10B deal

AbbVie to acquire ImmunoGen in $10B deal

YahooYahoo Finance Video

Top videos

AbbVie donates $35 million to COVID-19 relief efforts

AbbVie donates $35 million to COVID-19 relief efforts

CNBCLouise Connelly

AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond

AbbVie is the preeminent large-cap name in biotech, says Piper Sandler's Raymond

AbbVie | LinkedIn

AbbVie | LinkedIn

AbbVie Stock

Abbvie CEO on Allergan acquisition, Covid-19's effect on demand and more

Abbvie CEO on Allergan acquisition, Covid-19's effect on demand and more

CNBCJordan Smith

abbvie-stock-holds-support-and-gives-traders-a-buying-opportunity

abbvie-stock-holds-support-and-gives-traders-a-buying-opportunity

Stephanie Link: Abbvie has good guidance

Stephanie Link: Abbvie has good guidance